TRILLIUM THERAPEUTICS INC - COM NEW

CUSIP: 89620X506

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM NEW
Total 13F shares
380,248
Share change
+341,465
Total reported value
$3,422,500
Price per share
$9.00
Number of holders
6
Value change
+$3,073,500
Number of buys
4

Quarterly Holders Quick Answers

What is CUSIP 89620X506?
CUSIP 89620X506 identifies 89620X506 - TRILLIUM THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q4 2014

As of 31 Dec 2014, TRILLIUM THERAPEUTICS INC - COM NEW was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 380,248 shares. The largest 6 holders included Opaleye Management Inc., K2 PRINCIPAL FUND, L.P., Longwood Capital Partners LLC, THOMPSON DAVIS & CO., INC., Tower Research Capital LLC (TRC), and FNY Managed Accounts LLC. This page lists 6 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.